Skip to main content
. Author manuscript; available in PMC: 2021 Aug 11.
Published in final edited form as: Radiother Oncol. 2019 Oct 12;143:51–57. doi: 10.1016/j.radonc.2019.07.016

Table 1.

Specifics for the established significant associations (p≤0.0056) between the investigated WBC variables and the treatment outcomes.

Outcome Modeling WBC variable p β HR (95%CI)

Overall survival Univariate N Δ4mo 0.00001 0.61 1.8 (1.4–2.4)
N/L Δ4mo 0.0003 0.16 1.2 (1.1–1.3)
Multivariate N Δ4mo 0.005 0.14 1.1 (1.0–1.3)
N/L Δ4mo 0.09 0.02 1.0 (1.0–1.0)

Regional recurrence Univariate L Δ12d 0.002 0.39 -
L Δ2mo 1E-10 0.12 -

Note: None of the WBCs predicted distant, local, or nodal recurrence (p-value range: 0.18–0.49, 0.13–0.49, 0.11–0.51); the p-values for the WBCs that did not predict OS and regional recurrence ranged between 0.02–0.67 and 0.008–0.47, respectively.